Soleno Therapeutics, Inc. (SLNO) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of $0.80, $0.19 better than the analyst estimate of $0.61. Revenue for the quarter came in at $91.73 million versus the consensus estimate of $82.45 million.
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Grizzly Discoveries closes private placement raising $349,044
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
